Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Giuseppe Paolazzi
Golimumab: A Novel Anti-Tumor Necrosis Factor
Biologics in Therapy
Related publications
Infliximab (Anti–Tumor Necrosis Factor Α Antibody)
Archives of Dermatology
Selective Improvement of Tumor Necrosis Factor Capture in a Cytokine Hemoadsorption Device Using Immobilized Anti-Tumor Necrosis Factor
Journal of Biomedical Materials Research - Part B Applied Biomaterials
Biomedical Engineering
Biomaterials
Tumor Necrosis Factor
CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
TRAF5, a Novel Tumor Necrosis Factor Receptor-Associated Factor Family Protein, Mediates CD40 Signaling.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Vasculoprotective Effects of Anti-Tumor Necrosis Factor-Α Treatment in Aging
American Journal of Pathology
Forensic Medicine
Pathology
Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis
JAMA Dermatology
Dermatology
Medicine
Reactivation of Hepatitis B Virus Following Anti-Tumor Necrosis Factor-Α Therapy
Soonchunhyang Medical Science
Preparation of Agarose-Glucan for Anti-Tumor Necrosis Factor Protein Drug Delivery
VNU Journal of Science: Natural Sciences and Technology